Newsletters
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
- All
- AMR Action Fund
- Can you help?
- CARB-X
- CDC
- FDA
- Government Action
- Jobs
- Meetings
- PK & PK-PD
- Push/Pull
- R&D Insight
- RFPs
- Something Different
- Summaries
- Wellcome Trust
- WHO
- Wonkish
AI-based drug discovery: Chemical vs. drugs (Part 4)
Note: Heads-up … I am told there are few spots left in the ICARe course that runs 7-15 Oct 2023 …
WHO-UNEP-FAO-OIE Youth Engagement Working Group on AMR: Apply now!
“Education is the most powerful weapon we can use to change the world…” — Nelson Mandela Dear All, Regular readers …
Reports calling for Pull: US GAO, Global AMR R&D Hub
Dear All, Two important reports for your awareness this afternoon. First, the Global AMR R&D hub have responded to a …
High Watermark for Pull Incentives (and more): Reflections on an amazing week!
Dear All, As a follow up to the glorious cacophony of the events occurring right at the end of April, …
European Commission: Proposed Pull incentives!
Note: Be sure to see the forward calendar: there is a webinar on 9 May during which Mark McClellan will …
AMR Hearing in Congress, PASTEUR re-introduced … and more!
Dear All, It’s been a busy 48 hours .. three (and a half) things for you! First up, you will …
US House Committee Hearing on AMR! Friday!
Dear All, At 9am ET on 28 April 2023, the Oversight and Investigations Subcommittee of the US House of Representatives Committee on …
AMR Hearing in Congress, WHO BPPL Survey, & Vivli AMR Data Challenge
Dear All, Three things today… First, there is a newly announced hearing by the House Energy and Commerce at 9AM …
The road to UNGA 2024: Global action on AMR!
Dear All, Greetings from ECCMID 2023 in Copenhagen! The days are busy, but last night we had a joint session …
WHO 2017 BPPL Survey, ENABLE-2 Call, OHE summary of NHS pilot
Dear All, A key theme of all discussions on Pull incentives is that substantial rewards should go only to molecules …
AMR Action: Letter to sign, letter to write, Bill Gates in NYT on fire extinguishers!
Dear All, Following hard on the heels of the very successful call for signatories of a letter in support of …
17 April 2023: FREE Masterclass from FDA / CARB-X wants you!
Dear All, Two quick items today. First, FDA have announced an Antimicrobial Drugs Advisory Committee on 17 April 2023 (9a-4.30p …
WHO 2023 Pipeline Update: Share Your Preclinical Antibacterial Projects!
Dear All, As you know, WHO updates their preclinical and clinical pipeline summaries at regular intervals. The most current reviews …
PASTEUR: Sign a letter to make it happen this year!
Dear All, As all regular readers of this newsletter know, I think that creation of suitable Pull incentives by passage …
AMR Action: UN Report → Global Governance → Pull from UK (‘Netflix’) and Japan
Dear All (and with thanks to Kevin for co-authoring), For today, a wonkish potpourri of data to support action. As you’ll see, this string …
JPIAMR Diagnostics Call / James Bond’s occupational exposures
Dear All, A short one today! Please peruse both the funding opportunities and upcoming meetings just below my signature. Of …
NIAID BAA – Biodefense focus / Fireside Chat on diagnostics and more
Dear All, We are swimming in Broad Agency Announcements aka BAAs! As a refresher, I recently shared a BAA from …
LPAD/Limited Use insights; NI margins for TB and candidiasis
Dear All, I want to call your attention to next week’s AMDAC (Antimicrobial Drugs Advisory Committee) for rezafungin. This meeting …
Notable webinars: Pediatric drug development; Drug delivery systems
Dear All, The high-value webinars below have just crossed my radar. First up, we have a very important 2-part webinar on …
CDC BAA: Surveillance, endpoints for decolonization, and more…
Dear All, Greetings in the new year! I just tonight picked up on this fascinating BAA (Broad Agency Announcement) from …
